Goldman Sachs Group Boosts Reckitt Benckiser Group (LON:RB) Price Target to GBX 7,000

Reckitt Benckiser Group (LON:RB) had its price objective lifted by Goldman Sachs Group from GBX 6,600 ($81.22) to GBX 7,000 ($86.14) in a report released on Thursday, Borsen Zeitung reports. They currently have a neutral rating on the stock.

A number of other research firms have also commented on RB. Berenberg Bank upped their price target on Reckitt Benckiser Group from GBX 8,000 ($98.45) to GBX 9,000 ($110.76) and gave the company a buy rating in a research report on Wednesday. Kepler Capital Markets upped their price target on Reckitt Benckiser Group from GBX 6,700 ($82.45) to GBX 7,250 ($89.22) and gave the company a buy rating in a research report on Monday, May 4th. Barclays upped their price target on Reckitt Benckiser Group from GBX 9,000 ($110.76) to GBX 9,400 ($115.68) and gave the company an overweight rating in a research report on Wednesday. JPMorgan Chase & Co. upped their price target on Reckitt Benckiser Group from GBX 8,000 ($98.45) to GBX 9,000 ($110.76) and gave the company an overweight rating in a research report on Wednesday. Finally, HSBC reiterated a buy rating and issued a GBX 8,300 ($102.14) price target on shares of Reckitt Benckiser Group in a research report on Monday, July 20th. Two analysts have rated the stock with a sell rating, four have issued a hold rating and thirteen have given a buy rating to the company’s stock. Reckitt Benckiser Group has a consensus rating of Buy and a consensus price target of GBX 7,655.56 ($94.21).

Shares of RB stock opened at GBX 7,706 ($94.83) on Thursday. The firm has a market capitalization of $54.80 billion and a P/E ratio of -14.83. Reckitt Benckiser Group has a twelve month low of GBX 73.44 ($0.90) and a twelve month high of GBX 8,191.30 ($100.80). The company has a quick ratio of 0.40, a current ratio of 0.56 and a debt-to-equity ratio of 130.80. The stock’s fifty day simple moving average is GBX 7,441.20 and its 200 day simple moving average is GBX 6,629.16.

The company also recently declared a dividend, which will be paid on Tuesday, September 29th. Investors of record on Thursday, August 20th will be paid a dividend of GBX 73 ($0.90) per share. This represents a yield of 0.94%. The ex-dividend date is Thursday, August 20th. Reckitt Benckiser Group’s dividend payout ratio (DPR) is currently -39.06%.

In related news, insider Nicandro Durante acquired 165 shares of the firm’s stock in a transaction on Wednesday, May 27th. The stock was purchased at an average cost of GBX 6,884 ($84.72) per share, with a total value of £11,358.60 ($13,978.10).

About Reckitt Benckiser Group

Reckitt Benckiser Group plc manufactures, markets, and sells health, hygiene, and home products. The company offers acne treatment creams, facial washes, and cleansing pads; disinfection, hygiene, and first aid products; condoms, sex toys, and lubricants; heartburn and indigestion solutions; and cough and chest congestion, multi-symptom, and sinus remedies for adults and children under the Clearasil, Dettol, Durex, Gaviscon, and Mucinex brands.

See Also: Discover Your Risk Tolerance

Analyst Recommendations for Reckitt Benckiser Group (LON:RB)

Receive News & Ratings for Reckitt Benckiser Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Reckitt Benckiser Group and related companies with MarketBeat.com's FREE daily email newsletter.